Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Saroja Pharma Industries India Ltd. Share Price
Day's Range
Day's Range
Low
₹0.00
High
₹0.00
Price Summary
| Previous Close | ₹33.00 |
|---|---|
| Day's Range | ₹0.00 - ₹0.00 |
| Open | ₹0.00 |
| 52 Week Range | ₹28.00 - ₹60.00 |
| Volume | 0 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 8.20 |
| TTM EPS (₹) | 4.02 |
| P/E Ratio | 14.68 |
| Book Value(₹) | 0.85 |
| PAT Margin (%) | 1.92 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 12.56 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | N/A | 539.12 |
| Expenses | N/A | N/A |
| PBT | N/A | 14.49 |
| Operating profit | N/A | 0.0 |
| Net profit | N/A | 10.34 |
About Saroja Pharma Industries India Ltd.
| Founded | 2019 |
|---|---|
| Managing Director | Biju Nair |
| NSE Symbol | SAROJA |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,49,803.33 | 1,861.00 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,79,219.17 | 6,705.00 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,52,417.21 | 4,524.00 | 3,165.00 - 3,165.00 |
| Apollo Hospitals Enterprise Ltd. | 1,23,273.78 | 8,589.50 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,16,115.65 | 1,439.95 | 1,165.70 - 1,165.70 |
| Dr. Reddy's Laboratories Ltd. | 1,10,874.16 | 1,351.00 | 1,148.40 - 1,148.40 |
| Zydus Lifesciences Ltd. | 1,09,635.65 | 1,100.70 | 835.50 - 835.50 |
| Lupin Ltd. | 1,08,263.52 | 2,346.00 | 1,836.80 - 1,836.80 |
| Max Healthcare Institute Ltd. | 1,05,217.39 | 1,121.00 | 903.00 - 903.00 |
| Mankind Pharma Ltd. | 1,02,255.74 | 2,462.80 | 1,909.70 - 1,909.70 |
No Records Found
Latest News
GlaxoSmithKline Pharmaceuticals informs about disclosure
Lotus Eye Hospital And Institute informs about trading window closure
Vista Pharmaceuticals informs about closure of trading window
Tejnaksh Healthcare informs about closure of trading window
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time and Company’s Code of Internal Procedures and Conduct for Prevention of Insider Trading in Securities, Tejnaksh Healthcare has informed that the Trading Window for dealing in Equity Shares of the Company shall remain close for Promoters, Directors, Designated Employees, and other connected or designated persons of the Company from July 01, 2026 till 48 hours after the declaration of Financial Results for the quarter and year ended June 30, 2026.
The above information is a part of company’s filings submitted to BSE.
Jupiter Life Line Hospitals informs about AGM
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Saroja Pharma Industries India Ltd. is ₹33.00 as of 2026-06-25.
The market capitalisation of Saroja Pharma Industries India Ltd. is ₹13.27 as of 2026-06-22.
The 1-year return of Saroja Pharma Industries India Ltd. is 0.00% as of 2026-06-25.
The P/E ratio of Saroja Pharma Industries India Ltd. is 14.68 as of 2026-06-25.
The 52-week high and low of Saroja Pharma Industries India Ltd. are ₹60.00 and ₹28.00, respectively, as of 2026-06-25.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
